Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

imidazopyrazole

Known as: 1H-imidazo(1,2-b)pyrazole 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (2)

NSC 51143imidazolopyrazole

Broader (1)

Pyrazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets
Several anti-inflammatory agents based on pyrazole and imidazopyrazole scaffolds and a large library of substituted catechol… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
2020
2020
Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems
Even though immunotherapy has radically changed the search for anticancer therapies, there are still many different pathways that… Expand
2017
2017
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis.
Taking into account the structure activity relationship information given by our previous studies, we designed and synthesized a… Expand
2016
2016
An Eco-Friendly Synthesis of Heterocyclic Moieties Condensed with Pyrazole System under Green Conditions and Their Biological Activity
The efficient, facile and green synthesis of 4-bromo pyrazolone by using N-bromo saccharine as valuable green reagent encouraged… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
2014
2014
Abstract 1026: Novel Tie2 inhibitor with in vivo efficacy in disseminated hematological tumor models in mice
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA The receptor tyrosine kinase Tie2 is predominantly… Expand
Highly Cited
2011
Highly Cited
2011
N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
On the basis of structures of known topoisomerase II catalytic inhibitors and initial molecular docking studies, bicyclic N-fused… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
1993
1993
Prepn. of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
The compounds of formula (I) shown below and a preparation method thereof can be applied in pharmaceutically acceptable salt… Expand
1989
1989
Imidazopyrazole derivatives and its pharmaceutical compositions
1982
1982
GC analysis of imidazopyrazole in plasma using nitrogen-specific detection.
A sensitive, specific GC assay for imidazopyrazole in plasma was developed using nitrogen-specific detection. The samples are… Expand
1980
1980
Studies on the Clinical Pharmacokinetics of Imidazopyrazole
Plasma decay kinetics were analyzed for seven patients (400-5700 mg) during a Phase I clinical trial of imidazopyrazole. A two… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE